Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

947
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
947
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

606
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
606
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

564
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
564
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1-phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study.

Clinical pharmacology in drug development·2024
Same author

Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.

Journal of Crohn's & colitis·2021
Same author

Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers.

Pulmonary circulation·2020
Same author

Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis.

Gastroenterology·2019
Same author

Recent developments in the science of proarrhythmic cardiac safety of new drugs.

European heart journal. Cardiovascular pharmacotherapy·2017
Same author

The Cardiac Safety Research Consortium enters its second decade: An invitation to participate.

American heart journal·2016

相关实验视频

Updated: May 6, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.3K

冠状动脉再血管化后的存活率,有或没有 mitra 手术,在患有缺血性 mitra 吐的患者中.

Benjamin H Trichon1, Donald D Glower, Linda K Shaw

  • 1Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA. trich001@mc.duke.edu

Circulation
|September 13, 2003
PubMed
概括
此摘要是机器生成的。

比如皮肤冠状动脉干预 (PCI),冠状动脉旁路移植 (CABG) 和伴随着心心膜手术的CABG等治疗方法,与单独的药物治疗相比,改善了缺血性心心回 (IMR) 患者的存活率.

更多相关视频

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.7K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.9K

相关实验视频

Last Updated: May 6, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

13.3K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.7K
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.9K

科学领域:

  • 心脏病学 心脏病学
  • 心脏外科手术 心脏外科手术
  • 干预心脏病学 干预心脏病学

背景情况:

  • 人们讨论了缺血额头吐 (IMR) 治疗策略.
  • 最佳管理需要在不同干预措施中比较生存率.

研究的目的:

  • 为了比较IMR患者接受医学治疗,PCI,CABG或CABG+中 (MV) 手术的存活率.
  • 评估各种IMR治疗方式的有效性.

主要方法:

  • 对2,757名IMR患者 (1986-2001) 的回顾性分析.
  • 使用多变量Cox比例危险建模和倾向评分方法.
  • 定义IMR为2级+心肌吐与显著的冠状动脉疾病.

主要成果:

  • 与医学治疗相比,PCI,CABG和CABG + MV手术与显著降低的死亡风险有关.
  • 与单独CABG相比,CABG + MV手术没有改善生存率.
  • 接受CABG + MV手术的患者呈现出更严重的额头骨吐和心力衰竭.

结论:

  • PCI,CABG和CABG + MV手术为IMR患者提供了比医疗管理更好的生存益处.
  • 虽然干预措施提高了生存率,但CABG和MV手术的结合在这个队列中没有比单独CABG提供额外的生存优势.